MoneyWorks4Me

Cohance Lifesciences - Quaterly Results

13 May 2026 Evaluate
The sales declined to Rs. 5675.50 millions for the March 2026 quarter as compared to Rs. 7685.70 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 345.60 millions for the quarter ended March 2026 a decline of -71.85% from Rs. 1227.70 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 1157.80 millions from 2309.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5675.50 7685.70 -26.16 20305.00 25044.30 -18.92 20305.00 25044.30 -18.92
Other Income -7.90 81.90 -109.65 447.30 648.40 -31.01 447.30 648.40 -31.01
PBIDT 1157.80 2309.60 -49.87 4991.40 8490.50 -41.21 4991.40 8490.50 -41.21
Interest 51.70 70.00 -26.14 224.60 367.00 -38.80 224.60 367.00 -38.80
PBDT 941.00 2081.80 -54.80 4472.10 7965.70 -43.86 4472.10 7965.70 -43.86
Depreciation 376.60 425.80 -11.55 1335.80 1465.10 -8.83 1335.80 1465.10 -8.83
PBT 564.40 1656.00 -65.92 3136.30 6500.60 -51.75 3136.30 6500.60 -51.75
TAX 218.80 428.30 -48.91 849.20 1588.80 -46.55 849.20 1588.80 -46.55
Deferred Tax 8.00 120.90 -93.38 68.20 -124.30 -154.87 68.20 -124.30 -154.87
PAT 345.60 1227.70 -71.85 2287.10 4911.80 -53.44 2287.10 4911.80 -53.44
Equity 382.60 254.60 50.27 382.60 254.60 50.27 382.60 254.60 50.27
PBIDTM(%) 20.40 30.05 -32.11 24.58 33.90 -27.49 24.58 33.90 -27.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..